Posted by Michael Wonder on 22 Nov 2017
FDA approves first implanted lens that can be adjusted after cataract surgery to improve vision without eyeglasses in some patients
22 November 2017 - FDA approved the RxSight Inc. Light Adjustable Lens and Light Delivery Device, which can make small adjustments to the implanted lens after cataract surgery.
The U.S. FDA today approved the RxSight Inc. Light Adjustable Lens and Light Delivery Device, the first medical device system that can make small adjustments to the artificial lens’ power after cataract surgery so that the patient will have better vision when not using glasses.
Cataracts are a common eye condition where the natural lens becomes clouded, impairing a patient’s vision. Following cataract surgery, during which the natural lens of the eye that has become cloudy is removed and replaced with an artificial lens (intra-ocular lens, or IOL), many patients have some minor residual refractive error requiring use of glasses or contact lenses. Refractive error, which is caused when the artificial lens does not focus properly, causes blurred vision.
